Efficacy and Safety of Combined Autologous Blood and Minocycline Pleurodesis for Intractable Pneumothorax in High-Risk Non-Surgical Patients: A Case Series. [PDF]
This case series suggests that sequential, non‐mixed autologous blood plus minocycline pleurodesis is a feasible option for intractable secondary spontaneous pneumothorax (SSP) in high‐risk, nonsurgical patients, many of whom had ILD and/or severe COPD.
Koh E, Sekine Y.
europepmc +2 more sources
Successful Combined Autologous Blood and Minocycline Pleurodesis for Intractable Bilateral Pneumothorax in an Elderly Patient With Combined Pulmonary Fibrosis and Emphysema: A Case Report. [PDF]
We describe reproducible, complication‐free control of bilateral pneumothoraces in an octogenarian with CPFE using combined autologous blood and minocycline pleurodesis. ABSTRACT Bilateral pneumothorax in elderly patients with combined pulmonary fibrosis and emphysema (CPFE) is rare and often precludes surgery.
Koh E.
europepmc +2 more sources
Synergistic Sealing of the Pleural Space: Combining Thoracoscopic Talc Poudrage and IPC for Malignant Pleural Effusion-A Case Series. [PDF]
We describe the technique of performing talc poudrage and indwelling pleural catheter (IPC) insertion during the same setting to enhance procedural efficiency and patient outcomes. We report a case series of malignant pleural effusion demonstrating successful pleurodesis within 2–4 weeks using this combined approach.
Mohamad Jailaini MF +3 more
europepmc +2 more sources
Persistent Low-Output Neonatal Chylothorax: How Long Are We Justified to Wait for Pleurodesis in Partial Responders? [PDF]
ABSTRACT Aims The aim of our study was to review our experience regarding the management of neonatal chylothorax, with particular focus on outcomes of partial responders. Methods We conducted a retrospective analysis of neonatal chylothorax cases between January 2015 and December 2023.
Rollo G +9 more
europepmc +2 more sources
Intrapleural Administration of Hypotonic Cisplatin for Patients With Malignant Pleural Effusions and Non-Expandable Lungs. [PDF]
Intrapleural administration of hypotonic cisplatin (HPT) decreased or stabilized pleural effusions and was well tolerated in patients with malignant pleural effusion and non‐expandable lungs. ABSTRACT Background/Objectives Thoracostomy and pleurodesis are the mainstay of management for malignant pleural effusions (MPEs). However, pleurodesis may not be
Mori W +9 more
europepmc +2 more sources
Background Malignant pleural effusion (MPE) arises in advanced stages of malignancies and frequently carries a poor prognosis. The most common management of the patients with refractory MPE is pleurodesis.
Mohammed M.N AboZaid +2 more
doaj +1 more source
Summary: Background/Purpose: Pleurodesis with biomaterial implant is an emerging treatment method for pleural diseases. However, the ideal biomaterial or the optimal form for the common diseases is still under investigation.
Cheng-Hung How +5 more
doaj +1 more source
Pleurabrade: A Spiral Brush for Mechanical Pleurodesis and a Review of the Literature
Background While the optimal treatment for primary spontaneous pneumothorax remains unclear, mechanical pleurodesis is a well-established treatment. The Pleurabrade is a spiral brush designed for mechanical pleurodesis during thoracoscopy. We present two
John S. Young +3 more
doaj +1 more source
Repeated thoracentesis may cause pleural inflammation and induce local release of proinfammatory cytokine as tumor necrosis factor-α (TNF-α) which may subsequently enhance the release of plasminogen activator inhibitor-1 (PAI-1) and lead to fibrin ...
Adel Salah +3 more
doaj +1 more source
Background Malignant pleural effusion (MPE) is prevalent, and in cases such as aging patients as well as increased long-term survival for metastatic cancers, the number of patients will continue to elevate in the near future.
Adel M Saeed +3 more
doaj +1 more source

